Prior to the coronavirus pandemic, caregiver burnout and moral injury were significant and growing issues for clinical staff in virtually every specialty. That trend has only become more acute with the incredible pressures created by COVID-19.
How do healthcare leaders ensure they are supporting their caregivers in ways that don’t just keep them going through the acute phase of the coronavirus crisis, but also build resilience in the long-term?
The Forum for Healthcare Strategists is partnering with Jarrard Phillips Cate & Hancock to bring you this exclusive webinar on “caring for the caregivers.” Join health system leaders from across the country to hear insights and best practices for engaging with and caring for the clinical professionals who are working day in and day out to stem the tide of COVID-19.
Speakers:
Tony Briningstool, MD, FACEP
Senior Vice President & Chief Medical Officer @American Physician Partners
David Gaines
CEO, System Retail Services & Senior Vice President of Public Affairs @Ochsner Health
Lisa Sgarlata, DNP, MSFM, RN, FACHE
Chief Patient Care Officer & Chief Nurse Executive @Lee Health
Moderator:
Hollie Adams, MHA
Interim Health Services Practice Leader @Jarrard Phillips Cate & Hancock
We are the premier source for professional development for healthcare marketing, strategy, and physician relations executives.
In the face of staffing shortages, increased competition to attract quality candidates, burnout, and employees leaving the healthcare industry, culture can be a powerful tool for engagement ...read more
The time is NOW for healthcare organizations to connect in a meaningful way with employees, communities, and patients! Join this webinar to hear highlights from Humanizing Brand Experience ...read more
Countless tools and strategies are available for building successful patient acquisition programs, yet healthcare marketers repeatedly encounter the same challenges. Time and time ...read more
The moment has arrived. With worldwide hope focused on a COVID vaccine, two vaccines … from Moderna and Pfizer … await emergency use authorization from the FDA. Indeed, ...read more